The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours
Authors:
- Andreas I. ConstantinouACAndreas I. Constantinou
- Bethany E.P. WhiteBWBethany E.P. White
- Debra TonettiDTDebra Tonetti
- Yanan YangYYYanan Yang
- Wenzhong LiangWLWenzhong Liang
- Wenkui LiWLWenkui Li
- Richard B. van BreemenRBRichard B. van Breemen
- 1 March 2005
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 41 (4) , 647-654
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Equol Is a Novel Anti-Androgen that Inhibits Prostate Growth and Hormone Feedback1Biology of Reproduction, 2004
- Chemopreventive Effects of Soy Protein and Purified Soy Isoflavones on DMBA-Induced Mammary Tumors in Female Sprague-Dawley RatsNutrition and Cancer, 2001
- Infantile leukemia and soybeans – a hypothesisLeukemia, 1999
- Genistein-Mediated Attenuation of Tamoxifen-Induced Antagonism from Estrogen Receptor-Regulated GenesBiochemical and Biophysical Research Communications, 1998
- Antioxidant Efficacy of Phytoestrogens in Chemical and Biological Model SystemsArchives of Biochemistry and Biophysics, 1998
- Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen ReceptorEndocrinology, 1998
- Chemoprevention of N‐Nitroso‐N‐methylurea‐induced Rat Mammary Cancer by Miso and Tamoxifen, Alone and in CombinationJapanese Journal of Cancer Research, 1998
- Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cellsin vitroNutrition and Cancer, 1997
- Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivativesBiochemical Pharmacology, 1994
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994